Entrepreneurship and innovation enable Weill Cornell Medicine to bring discoveries to patients faster.

Weill Cornell Medicine investigators enjoy robust programs dedicated to nurturing, protecting and commercializing their discoveries. By translating groundbreaking research into revolutionary care through commercial partnerships, lifechanging diagnostics, treatments and healthcare solutions can reach patients faster than ever before. Weill Cornell Medicine Enterprise Innovation fosters a culture of innovation and entrepreneurship to build the next generation of leaders in life sciences industries and new ventures.

Enterprise Innovation

Weill Cornell Medicine Enterprise Innovation engages and collaborates with Weill Cornell Medicine faculty and trainees while fostering alliances with leaders in the biomedical industry and business and investment community.

Conference Showcases Biomedical Innovation at the Intersection of Business and Science

The 2024 Startup Symposium & InvestConnect Conference celebrated scientific inquiry and the entrepreneurial spirit.

Parker Institute for Cancer Immunotherapy (PICI) Welcomes Weill Cornell Medicine to Cancer Research Consortium

Weill Cornell Medicine establishes cancer immunology research center in New York City with PICI Funding.

Accelerating BioVenture Innovation Participants Pitch Tri-Institutional Technologies to Early-Stage Venture Capitalists

BioVenture eLab celebrated the hard work of its 2023 Accelerating BioVenture Innovation cohort with a pitch event on Dec. 6 in Uris Auditorium.

Deep Brain Stimulation Improves Cognition During Chronic Recovery Phase of Brain Injury

Deep brain stimulation (DBS) shown to substantially improve cognition and quality of life for people who suffered traumatic brain injuries.
Views on Innovation
Dr. McGinty
Dr. Barbara Hempstead, Dean, Weill Cornell Graduate School of Medical Sciences
Our accomplished physicians and scientists have a legacy of catalyzing research discoveries into new modalities and therapies that help transform human health.
Dr. John P. Leonard, Senior Associate Dean of Innovation and Initiatives
Getting new innovations across the finish line requires collaboration, often with industry partners, to scale up findings for application in healthcare.
Dr. William Polvino, CEO of Bridge Medicines
Tri-Institutional Therapeutics Discovery Institute and Bridge Medicines put the skill of a pharmaceutical company on the campuses of three great institutions.
Dr. Francis Barany
Dr. Francis Barany, Professor of Microbiology and Immunology
The professionals at Enterprise Innovation possess strong first-hand knowledge of what it takes to start a company.